The criteria for selection of these genes are their key role on the enhancement of apoptosis and a high fold change value in more than one dataset (FAS and PMAIP1), being the main negative regulation of p53 (MDM2), and the relevance of the genes to future study of PCOS pathogenesis. The gene discussed is MDM2; the disease is polycystic ovary syndrome.